{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:32:41Z","timestamp":1786991561435,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.jbspin.2015.01.002","type":"journal-article","created":{"date-parts":[[2015,3,14]],"date-time":"2015-03-14T02:36:52Z","timestamp":1426300612000},"page":"141-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Hyperuricemia starts at 360 micromoles (6mg\/dL)"],"prefix":"10.1016","volume":"82","author":[{"given":"Thomas","family":"Bardin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2015.01.002_bib0190","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nrrheum.2014.124","article-title":"Improving cardiovascular and renal outcomes in gout: what should we target?","volume":"10","author":"Richette","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0195","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/BOR.0000000000000028","article-title":"Definition of hyperuricemia and gouty conditions","volume":"26","author":"Bardin","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0200","series-title":"Rhumatologie. Pathologie osseuse et articulaire","author":"Ryckewaert","year":"1987"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0205","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","article-title":"Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008","volume":"63","author":"Zhu","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0210","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/annrheumdis-2011-201254","article-title":"Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study","volume":"7","author":"Trifiro","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0215","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/clinchem\/11.3.427","article-title":"Comparison of a colorimetric (automated) with an enzymatic (manual) uric acid procedure","volume":"11","author":"O'Sullivan","year":"1965","journal-title":"Clin Chem"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0220","first-page":"447","article-title":"Hyperuri\u00e9mie. I Remarque sur les methodes de mesure de l\u2019uric\u00e9mie dans le sang\u00a0; definition de l\u2019uric\u00e9mie normale","volume":"32","author":"Ryckewaert","year":"1965","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0225","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1056\/NEJM197209282871308","article-title":"Serum urate in healthy men. Intermittent elevations and seasonal effect","volume":"287","author":"Goldstein","year":"1972","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0230","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/rheumatology\/keh379","article-title":"Intermittent elevation of serum urate and 24-hour urinary uric acid excretion","volume":"43","author":"Yu","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0235","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/ard.41.3.272","article-title":"Serum uric acid levels among thirty-four thousand people in Japan","volume":"41","author":"Akizuki","year":"1982","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0240","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0002-9343(67)90004-6","article-title":"Epidemiology of gout and hyperuricemia. A long-term population study","volume":"42","author":"Hall","year":"1967","journal-title":"Am J Med"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0245","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0002-9343(65)90048-3","article-title":"The distribution of serum uric acid values in a population unselected as to gout or hyperuricemia: Tecumseh, Michigan 1959-1960","volume":"39","author":"Mikkelsen","year":"1965","journal-title":"Am J Med"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0250","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/ard.36.5.420","article-title":"Serum uric acid in England and Scotland","volume":"36","author":"Sturge","year":"1977","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0255","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00270308","article-title":"Rheumatic complaints in Tokelau, II. A comparison of migrants in New Zealand and non-migrants. The Tokelau Island migrant study","volume":"7","author":"Wigley","year":"1987","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0260","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/art.1780380508","article-title":"Racial differences in the incidence of gout. The role of hypertension","volume":"38","author":"Hochberg","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0265","doi-asserted-by":"crossref","first-page":"R116","DOI":"10.1186\/ar2519","article-title":"Menopauses, postmenopausal hormone use, and serum uric acid in US women: the Third National Health and Nutrition Examination Survey","volume":"10","author":"Hak","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0270","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/art.1780260115","article-title":"Trends in serum uric acid levels 1961\u20131980","volume":"26","author":"Glynn","year":"1983","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0275","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/art.1780150209","article-title":"The influence of temperature on the solubility of monosodium urate","volume":"15","author":"Loeb","year":"1972","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0280","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1172\/JCI102483","article-title":"Joint temperature measurement in the evaluation of anti-arthritic agents","volume":"30","author":"Hollander","year":"1951","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0285","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/ard.50.8.558","article-title":"Evidence for a promoter of urate crystal formation in gouty synovial fluid","volume":"50","author":"McGill","year":"1991","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0290","series-title":"Uric acid","first-page":"347","article-title":"Role of proteoglycans in the development of gouty arthritis","author":"Katz","year":"1978"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0295","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/rheumatology\/ken087","article-title":"Gout and nodal osteoarthritis: a case-control study","volume":"47","author":"Roddy","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbspin.2012.08.012","article-title":"Gout: the mechanism of urate crystal nucleation and growth. A hypothesis based in facts","volume":"80","author":"Pascual","year":"2013","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0305","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/ard.56.11.696a","article-title":"Serum uric acid in acute gout","volume":"56","author":"Logan","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0310","first-page":"2265","article-title":"Serum urate during bouts of acute gouty arthritis","volume":"24","author":"Schlesinger","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0315","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/ard.37.5.466","article-title":"A prospective study of gout in New Zealand Maoris","volume":"37","author":"Brauer","year":"1978","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0320","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0002-9343(87)90441-4","article-title":"Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study","volume":"82","author":"Campion","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0325","first-page":"1045","article-title":"Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen","volume":"27","author":"Lin","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0330","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10067-011-1802-6","article-title":"Gender-specific risk factors for incident gout: a prospective cohort study","volume":"31","author":"Chen","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0335","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/art.27338","article-title":"Epidemiology of gout in women. Fifty-two-year follow-up of a prospective cohort","volume":"62","author":"Bhole","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0340","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10067-014-2520-7","article-title":"The degree of asymptomatic hyperuricemia and the risk of gout. A retrospective analysis of a large cohort","volume":"33","author":"Duskin-Bitan","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0345","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/annrheumdis-2012-202301","article-title":"A systematic review of ultrasonography in gout and asymptomatic hyperuricaemia","volume":"72","author":"Chowalloor","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0350","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/ard.29.5.461","article-title":"Scott, clinical survey of 354 patients with gout","volume":"29","author":"Grahame","year":"1970","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0355","first-page":"109","article-title":"[Blood uric acid levels in gout patients]","volume":"8","author":"Ryckewaert","year":"1966","journal-title":"Rein Foie"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0360","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","article-title":"EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0365","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/acr.20344","article-title":"Hyperuricemia and incident hypertension: a systematic review and meta-analysis","volume":"63","author":"Grayson","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jbspin.2015.01.002_bib0370","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1136\/annrheumdis-2012-201916","article-title":"Serum urate association with hypertension in young adults: analysis from the coronary artery risk development in young adults cohort","volume":"72","author":"Gaffo","year":"2013","journal-title":"Ann Rheum Dis"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X15000032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X15000032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T17:45:01Z","timestamp":1598809501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X15000032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1297319X15000032"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2015.01.002","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperuricemia starts at 360 micromoles (6mg\/dL)","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2015.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}